As Apollo Invt Com (AINV) Share Price Declined, Holder Assetmark Decreased Its Position by $939,684; Abbvie (ABBV) Stock Value Rose While Apriem Advisors Cut Its Position

November 15, 2017 - By Peter Erickson

Assetmark Inc decreased its stake in Apollo Invt Corp Com (AINV) by 96.34% based on its latest 2017Q2 regulatory filing with the SEC. Assetmark Inc sold 156,614 shares as the company’s stock declined 0.16% while stock markets rallied. The institutional investor held 5,957 shares of the company at the end of 2017Q2, valued at $38,000, down from 162,571 at the end of the previous reported quarter. Assetmark Inc who had been investing in Apollo Invt Corp Com for a number of months, seems to be less bullish one the $1.31B market cap company. The stock declined 1.07% or $0.07 reaching $6.01 per share. About 51,471 shares traded. Apollo Investment Corp. (NASDAQ:AINV) has risen 17.01% since November 15, 2016 and is uptrending. It has outperformed by 0.31% the S&P500.

Apriem Advisors decreased its stake in Abbvie Inc (ABBV) by 6.03% based on its latest 2017Q2 regulatory filing with the SEC. Apriem Advisors sold 5,706 shares as the company’s stock rose 6.17% with the market. The institutional investor held 88,961 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $6.45 million, down from 94,667 at the end of the previous reported quarter. Apriem Advisors who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $148.43 billion market cap company. The stock declined 1.73% or $1.64 reaching $93.11 per share. About 920,172 shares traded. AbbVie Inc (NYSE:ABBV) has risen 10.63% since November 15, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

More news for Apollo Investment Corp. (NASDAQ:AINV) were recently published by: Businesswire.com, which released: “Apollo Investment Corporation Reports Financial Results for the Quarter Ended …” on November 03, 2017. Seekingalpha.com‘s article titled: “Apollo Investment Corp. Is Undervalued” and published on July 31, 2017 is yet another important article.

Analysts await Apollo Investment Corp. (NASDAQ:AINV) to report earnings on February, 5. They expect $0.16 earnings per share, down 5.88% or $0.01 from last year’s $0.17 per share. AINV’s profit will be $34.88 million for 9.39 P/E if the $0.16 EPS becomes a reality. After $0.16 actual earnings per share reported by Apollo Investment Corp. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Assetmark Inc, which manages about $13.57 billion and $7.95B US Long portfolio, upped its stake in Ishares Tr Us Treasury Etf (GOVT) by 170,499 shares to 1.60 million shares, valued at $40.44 million in 2017Q2, according to the filing. It also increased its holding in General Mtrs Co Com (NYSE:GM) by 133,463 shares in the quarter, for a total of 464,901 shares, and has risen its stake in Vanguard Scottsdale Fds Mortg (VMBS).

Among 16 analysts covering Apollo Investment (NASDAQ:AINV), 7 have Buy rating, 1 Sell and 8 Hold. Therefore 44% are positive. Apollo Investment had 28 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating by RBC Capital Markets given on Sunday, November 5. The stock has “Buy” rating by SunTrust on Friday, November 3. Cantor Fitzgerald maintained Apollo Investment Corp. (NASDAQ:AINV) on Sunday, August 9 with “Buy” rating. As per Thursday, October 5, the company rating was maintained by Keefe Bruyette & Woods. The stock of Apollo Investment Corp. (NASDAQ:AINV) earned “Hold” rating by BMO Capital Markets on Friday, October 6. The stock of Apollo Investment Corp. (NASDAQ:AINV) has “Neutral” rating given on Friday, August 21 by Citigroup. The firm earned “Buy” rating on Tuesday, September 1 by Cantor Fitzgerald. The company was maintained on Wednesday, November 1 by JP Morgan. The rating was initiated by DA Davidson with “Neutral” on Wednesday, September 30. The stock of Apollo Investment Corp. (NASDAQ:AINV) earned “Buy” rating by UBS on Monday, September 14.

Investors sentiment increased to 1.12 in Q2 2017. Its up 0.03, from 1.09 in 2017Q1. It is positive, as 13 investors sold AINV shares while 52 reduced holdings. 18 funds opened positions while 55 raised stakes. 96.57 million shares or 2.16% more from 94.52 million shares in 2017Q1 were reported. Meridian Inv Counsel holds 0.61% or 159,825 shares. Sumitomo Mitsui Asset Mngmt Com Ltd stated it has 0.09% of its portfolio in Apollo Investment Corp. (NASDAQ:AINV). Lpl Fincl Limited Liability Corporation owns 185,217 shares. Cap One Association reported 10,218 shares. Pacad Invest holds 7,100 shares or 0.01% of its portfolio. Bluecrest Capital Management Limited invested in 11,575 shares or 0% of the stock. Greenwich Investment Management holds 4.41% or 591,300 shares in its portfolio. Two Sigma has 0.06% invested in Apollo Investment Corp. (NASDAQ:AINV). Ahl Ptnrs Llp holds 0.09% in Apollo Investment Corp. (NASDAQ:AINV) or 686,774 shares. Glenmede Tru Na has invested 0% in Apollo Investment Corp. (NASDAQ:AINV). Invesco Ltd holds 0% in Apollo Investment Corp. (NASDAQ:AINV) or 2.31M shares. Pnc Service Group accumulated 0% or 5,932 shares. Catalyst Cap Advisors Ltd Liability holds 115,463 shares or 0.03% of its portfolio. Jane Street Grp Inc Limited Liability Corporation holds 12,186 shares. Moreover, Green Square Cap Lc has 0.07% invested in Apollo Investment Corp. (NASDAQ:AINV) for 56,976 shares.

Analysts await AbbVie Inc (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28B for 16.28 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc for the previous quarter, Wall Street now forecasts 1.42% EPS growth.

Investors sentiment increased to 1 in 2017 Q2. Its up 0.01, from 0.99 in 2017Q1. It improved, as 55 investors sold ABBV shares while 581 reduced holdings. 138 funds opened positions while 500 raised stakes. 1.04 billion shares or 0.53% more from 1.04 billion shares in 2017Q1 were reported. Northern Capital Mngmt Ltd Liability Corp invested in 0.12% or 4,280 shares. Neville Rodie Shaw Inc reported 1.07% stake. Stifel invested in 0.78% or 2.89M shares. American Rech And Mgmt Company reported 1,887 shares. Godshalk Welsh Inc has 0.65% invested in AbbVie Inc (NYSE:ABBV). Girard Prtnrs has 13,665 shares for 0.21% of their portfolio. Todd Asset Mgmt Ltd Limited Liability Company stated it has 0.03% in AbbVie Inc (NYSE:ABBV). Knott David M holds 2.12% or 70,200 shares in its portfolio. Hutchin Hill LP has invested 0.07% in AbbVie Inc (NYSE:ABBV). Donaldson Capital Mgmt Ltd Limited Liability Company stated it has 418,931 shares or 3.44% of all its holdings. Connors Investor holds 141,271 shares. Clean Yield Gp Inc has invested 0.29% in AbbVie Inc (NYSE:ABBV). Atria Investments Limited Liability Co, North Carolina-based fund reported 85,167 shares. 5,125 were accumulated by Independent Port Consultants. United Fire Group Inc holds 225,000 shares or 5.79% of its portfolio.

More notable recent AbbVie Inc (NYSE:ABBV) news were published by: Bloomberg.com which released: “AbbVie Overpromises” on November 03, 2017, also Seekingalpha.com with their article: “AbbVie: Another Spectacular Quarter From This Dividend Aristocrat” published on October 28, 2017, Nasdaq.com published: “Physicians Financial Services, Inc. Buys DowDuPont Inc, Red Hat Inc, AbbVie …” on November 02, 2017. More interesting news about AbbVie Inc (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie inks $225M neurodegenerative drug development deal with Alector” published on October 24, 2017 as well as Nasdaq.com‘s news article titled: “Can AbbVie (ABBV) Spring a Surprise this Earnings Season?” with publication date: October 24, 2017.

Since May 18, 2017, it had 0 insider buys, and 2 selling transactions for $8.79 million activity. CHASE WILLIAM J had sold 38,300 shares worth $2.50M on Thursday, May 18. Schumacher Laura J sold $5.59M worth of stock or 79,800 shares. Another trade for 45,800 shares valued at $3.21M was made by ALBAN CARLOS on Wednesday, June 14.

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 66 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, July 22 by SunTrust. The company was maintained on Monday, July 17 by Deutsche Bank. Piper Jaffray maintained AbbVie Inc (NYSE:ABBV) on Thursday, September 28 with “Buy” rating. As per Monday, October 2, the company rating was upgraded by Leerink Swann. The stock of AbbVie Inc (NYSE:ABBV) has “Mkt Perform” rating given on Tuesday, October 18 by Leerink Swann. SunTrust maintained AbbVie Inc (NYSE:ABBV) on Monday, October 16 with “Buy” rating. As per Thursday, July 20, the company rating was maintained by Credit Suisse. Societe Generale initiated AbbVie Inc (NYSE:ABBV) on Wednesday, April 6 with “Sell” rating. As per Tuesday, December 1, the company rating was downgraded by Barclays Capital. The firm has “Buy” rating given on Friday, September 15 by Jefferies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.